These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 11576357

  • 1. Autoregulated glomerular filtration rate during candesartan treatment in hypertensive type 2 diabetic patients.
    Christensen PK, Lund S, Parving HH.
    Kidney Int; 2001 Oct; 60(4):1435-42. PubMed ID: 11576357
    [Abstract] [Full Text] [Related]

  • 2. Autoregulation of glomerular filtration rate in patients with type 2 diabetes during isradipine therapy.
    Christensen PK, Akram K, Kønig KB, Parving HH.
    Diabetes Care; 2003 Jan; 26(1):156-62. PubMed ID: 12502673
    [Abstract] [Full Text] [Related]

  • 3. Autoregulation of glomerular filtration rate during spironolactone treatment in hypertensive patients with type 1 diabetes: a randomized crossover trial.
    Schjoedt KJ, Christensen PK, Jorsal A, Boomsma F, Rossing P, Parving HH.
    Nephrol Dial Transplant; 2009 Nov; 24(11):3343-9. PubMed ID: 19561152
    [Abstract] [Full Text] [Related]

  • 4. Candesartan cilexetil and renal hemodynamics in hypertensive patients.
    Fridman K, Wysocki M, Friberg P, Andersson OK.
    Am J Hypertens; 2000 Sep; 13(9):1045-8. PubMed ID: 10981559
    [Abstract] [Full Text] [Related]

  • 5. Optimal dose of candesartan for renoprotection in type 2 diabetic patients with nephropathy: a double-blind randomized cross-over study.
    Rossing K, Christensen PK, Hansen BV, Carstensen B, Parving HH.
    Diabetes Care; 2003 Jan; 26(1):150-5. PubMed ID: 12502672
    [Abstract] [Full Text] [Related]

  • 6. The efficacy and tolerability of candesartan cilexetil in an elderly hypertensive population.
    McInnes GT, O'Kane KP, Jonker J, Roth J.
    J Hum Hypertens; 1997 Sep; 11 Suppl 2():S75-80. PubMed ID: 9331015
    [Abstract] [Full Text] [Related]

  • 7. Dual blockade of the renin-angiotensin system in diabetic nephropathy: a randomized double-blind crossover study.
    Rossing K, Christensen PK, Jensen BR, Parving HH.
    Diabetes Care; 2002 Jan; 25(1):95-100. PubMed ID: 11772908
    [Abstract] [Full Text] [Related]

  • 8. The impact of glycaemic control on autoregulation of glomerular filtration rate in patients with non-insulin dependent diabetes.
    Christensen PK, Lund S, Parving HH.
    Scand J Clin Lab Invest; 2001 Feb; 61(1):43-50. PubMed ID: 11300610
    [Abstract] [Full Text] [Related]

  • 9. Acute effects of candesartan cilexetil (the new angiotensin II antagonist) on systemic and renal haemodynamics in hypertensive patients.
    Fridman K, Andersson OK, Wysocki M, Friberg P, Sunzel M.
    Eur J Clin Pharmacol; 1998 Sep; 54(7):497-501. PubMed ID: 9832289
    [Abstract] [Full Text] [Related]

  • 10. Differences between nisoldipine and lisinopril on glomerular filtration rates and albuminuria in hypertensive IDDM patients with diabetic nephropathy during the first year of treatment.
    Rossing P, Tarnow L, Boelskifte S, Jensen BR, Nielsen FS, Parving HH.
    Diabetes; 1997 Mar; 46(3):481-7. PubMed ID: 9032106
    [Abstract] [Full Text] [Related]

  • 11. Clinical efficacy and tolerability of candesartan cilexetil. Candesartan Study Groups in Japan.
    Ogihara T, Arakawa K.
    J Hum Hypertens; 1999 Jan; 13 Suppl 1():S27-31; discussion S33-4. PubMed ID: 10076918
    [Abstract] [Full Text] [Related]

  • 12. Addition of manidipine improves the antiproteinuric effect of candesartan in hypertensive patients with type II diabetes and microalbuminuria.
    Fogari R, Corradi L, Zoppi A, Lazzari P, Mugellini A, Preti P, Rinaldi A.
    Am J Hypertens; 2007 Oct; 20(10):1092-6. PubMed ID: 17903693
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of 10-mg azilsartan compared with 8-mg candesartan cilexetil in Japanese patients with hypertension: a randomized crossover non-inferiority trial.
    Takahara M, Shiraiwa T, Shindo M, Arai A, Kusuda Y, Katakami N, Kaneto H, Matsuoka TA, Shimomura I.
    Hypertens Res; 2014 Sep; 37(9):852-7. PubMed ID: 24739538
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of the efficacy and tolerability of combination therapy with candesartan cilexetil and amlodipine besilate compared with candesartan cilexetil monotherapy and amlodipine besilate monotherapy in Japanese patients with mild-to-moderate essential hypertension: a multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Rakugi H, Ogihara T, Miyata Y, Sasai K, Totsuka N.
    Clin Ther; 2012 Apr; 34(4):838-48. PubMed ID: 22440192
    [Abstract] [Full Text] [Related]

  • 15. Autoregulated glomerular filtration rate during candesartan treatment in hypertensive type 2 diabetic patients.
    Mansour G, Mansour J.
    Curr Hypertens Rep; 2002 Dec; 4(6):437-8. PubMed ID: 12419171
    [No Abstract] [Full Text] [Related]

  • 16. Renoprotective effects of adding angiotensin II receptor blocker to maximal recommended doses of ACE inhibitor in diabetic nephropathy: a randomized double-blind crossover trial.
    Rossing K, Jacobsen P, Pietraszek L, Parving HH.
    Diabetes Care; 2003 Aug; 26(8):2268-74. PubMed ID: 12882847
    [Abstract] [Full Text] [Related]

  • 17. Disparate systemic and renal blocking properties of angiotensin II antagonists during exogenous angiotensin II administration: implications for treatment.
    Willemsen JM, Rabelink TJ, Boer P, Gaillard CA.
    J Hum Hypertens; 2004 Dec; 18(12):857-63. PubMed ID: 15361886
    [Abstract] [Full Text] [Related]

  • 18. Impaired autoregulation of the glomerular filtration rate in patients with nondiabetic nephropathies.
    Christensen PK, Hommel EE, Clausen P, Feldt-Rasmussen B, Parving HH.
    Kidney Int; 1999 Oct; 56(4):1517-23. PubMed ID: 10504503
    [Abstract] [Full Text] [Related]

  • 19. Impaired autoregulation of GFR in hypertensive non-insulin dependent diabetic patients.
    Christensen PK, Hansen HP, Parving HH.
    Kidney Int; 1997 Nov; 52(5):1369-74. PubMed ID: 9350661
    [Abstract] [Full Text] [Related]

  • 20. A placebo-controlled comparison of the efficacy and tolerability of candesartan cilexetil, 8 mg, and losartan, 50 mg, as monotherapy in patients with essential hypertension, using 36-h ambulatory blood pressure monitoring.
    Baguet JP, Nisse-Durgeat S, Mouret S, Asmar R, Mallion JM.
    Int J Clin Pract; 2006 Apr; 60(4):391-8. PubMed ID: 16620350
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.